Opexa Placement To Help Fund MS Cell Therapies

By Editorial Staff

August 18, 2008

Woodlands, Texas-based Opexa Therapeutics, which specializes in stem cell therapy, said it completed a $3 million private placement which will be used to finance the clinical development of cell therapies for multiple sclerosis.

The full article is available to Private Placement Letter subscribers only

SUBSCRIBE NOW!
$1,250 for 1 Year(48 issues in all) and Save 10%
Free Trial
Sign up for Private Placement Letter's 3-Week Free Trial

Already a print subscriber? As a print subscriber, you are entitled to online access. Please click here to activate your account.

Related Items